Metrics in Balance Valuation

Is MLMIB undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of MLMIB when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate MLMIB's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate MLMIB's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for MLMIB?

Key metric: As MLMIB is unprofitable and pre-revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for MLMIB. This is calculated by dividing MLMIB's market cap by their current book value.
What is MLMIB's PB Ratio?
PB Ratio	n/a
Book	€11.75m
Market Cap	€144.89k

MLMIB key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	n/a
Enterprise Value/EBITDA	n/a
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does MLMIB's PB Ratio compare to its peers?

The above table shows the PB ratio for MLMIB vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	0.7x
ALICR I.CERAM	0.5x	n/a	€178.2k
ALSPW Spineway	0.004x	97.7%	€73.3k
AFME Affluent Medical	2.1x	-33.4%	€65.3m
S2M S2Medical	0.2x	n/a	SEK 2.4m
MLMIB Metrics in Balance	n/a	n/a	€144.9k

Price-To-Book vs Peers: Insufficient data to calculate MLMIB's Price-To-Book Ratio vs. peers for valuation analysis.

Price to Book Ratio vs Industry

How does MLMIB's PB Ratio compare vs other companies in the FR Medical Equipment Industry?

1 Company	Price / Book	Estimated Growth	Market Cap

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: Insufficient data to calculate MLMIB's Price-To-Book Ratio vs. industry for valuation analysis.

Price to Book Ratio vs Fair Ratio

What is MLMIB's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

MLMIB PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	n/a
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate MLMIB's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Laboratoires Euromedis Société anonyme

€13.2m

Through its subsidiaries, designs, manufactures, and distributes medical equipment under the Euromedis brand name for healthcare professionals, local communities, and individuals in France and internationally.

ALEMG

€4.63

-2.9%

emeis Société anonyme

€839.2m

Operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals.

EMEIS

€5.21

-11.0%

-97.8%

bioMérieux

€11.6b

Develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.

BIM

€98.70

0.4%

0.08%